How to cite item

Successful treatment of lung adenocarcinoma with gefitinib based on EGFR gene amplification

   
@article{JTD24888,
	author = {Chunguo Wang and Feng Xu and Jianfei Shen and Linna Zhang and Jian Zhang and Jiang Jin and Luca Ampollini and Paul van Schil and Hideharu Kimura and Francesco Grossi and Kenichi Suda and Bo Zhang and Dehua Ma and written on behalf of the AME Lung Cancer Collaborative Group},
	title = {Successful treatment of lung adenocarcinoma with gefitinib based on EGFR gene amplification},
	journal = {Journal of Thoracic Disease},
	volume = {10},
	number = {11},
	year = {2018},
	keywords = {},
	abstract = {In the past, the optimal first-line treatment of advanced non-small cell lung cancer (NSCLC) patients with wild-type for epidermal growth factor receptor (wt-EGFR) has been platinum-based chemotherapy doublets (1,2). More recently, clinicians have adopted immunotherapy with check-point inhibitors alone, in PD-L1 strong positive, or combined with chemotherapy independently to PD-L1 expression (3).},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/24888}
}